Nature Biotechnology, Published online: 19 August 2026; doi:10.1038/s41587-026-03300-3 DNA writing is entering a period of rapid innovation, with enzymatic and cellular approaches challenging decades-old chemistry. Although none yet delivers long, accurate DNA at the scale biology ultimately requires, continued advances promise to remove one of the field’s most persistent bottlenecks and enable experiments that are currently out of reach.
ORIGINAL PAPER
From reading to writing
WHAT WE KNOW
Nature Biotechnology, Published online: 19 August 2026; doi:10.1038/s41587-026-03300-3 DNA writing is entering a period of rapid innovation, with enzymatic and cellular approaches challenging decades-old chemistry. Although none yet delivers long, accurate DNA at the scale biology ultimately requires, continued advances promise to remove one of the field’s most persistent bottlenecks and enable experiments that are currently out of reach.
WATCH NEXT
Review the primary source, validate the main result, and establish whether any listed-company transmission is direct.
EVIDENCE
What the evidence supports so far
Research signals
Classification pending.
What remains unverified
The full methodology, effect size, and limitations still require analyst review.
Company impact remains unverified until a direct economic transmission is established.